Clinical study of China officinalis in the view of classical systemic homeopathy during COVID-19 epidemic in São Paulo

Background: Brazilian Ministry of Health has reported 5.273.954 cases and 154.837 deaths from COVID-19 on October 20th, 2020. The first case in Brazil occurred February 26th, São Paulo state. A total 351.877 13.331 were only the city 20th. This scenario severe health, economic, social impact, as other countries. Therefore, treatment strategies are urgently needed, such Homeopathy that shown excellent results several epidemics. Aims: study aims to describe health signs symptoms some healthcare essential professionals during use China officinalis. Methodology: Participants Server Public Municipal Hospital (HSPM), Nossa Senhora Rainha da Paz Association (RP), Padre Bento (HPB). homeopathic intervention was C. officinalis 6CH a dosage six drops per day. design time series with analysis by questionnaire before after using medicine. Statistical analyses done McNemar test compare qualitative data paired significance level 5%. Ethical approval is CAAE 31802720.0.0000.5442. Results discussion: Among HSPM RP participants, 83,1% did not develop while 16,9% developed HPB 87,8 % 12,2 . During usage officinalis, covid19-like reduced significant difference (p<0.05). symptomatic, none participants needed intensive care hospitalization, supplemental oxygen, or intubation. Conclusion: very acceptability its coronavirus pandemic contributed promotion.